Prestige Consumer Healthcare Inc. buy Oppenheimer Holdings Inc.
Start price
13.02.25
/
50%
€80.50
Target price
13.02.26
€89.17
Performance (%)
-31.06%
End price
14.02.26
€55.50
Summary
This prediction ended on 14.02.26 with a price of €55.50. The BUY prediction by Oppenheimer_Holdings for Prestige Consumer Healthcare Inc. performed very badly with a performance of -31.06%. Oppenheimer_Holdings has a follow-up prediction for Prestige Consumer Healthcare Inc. where he still thinks Prestige Consumer Healthcare Inc. is a Buy. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 3.390% | 3.390% | -29.784% |
| iShares Core DAX® | 2.287% | 9.963% | 14.444% |
| iShares Nasdaq 100 | 4.537% | 8.787% | 40.868% |
| iShares Nikkei 225® | 2.813% | 14.081% | 47.188% |
| iShares S&P 500 | 3.096% | 6.854% | 31.173% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Prestige Consumer Healthcare Inc. diskutieren
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target raised by analysts at Oppenheimer Holdings Inc. from $87.00 to $93.00. They now have an "outperform" rating on the stock.
Ratings data for PBH provided by MarketBeat
In the thread Trading Prestige Consumer Healthcare Inc.
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten
Current prediction by Oppenheimer_Holdings for Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc.
Start price
Target price
Perf. (%)
€53.00
21.10.25
21.10.25
€61.83
21.10.26
21.10.26
-7.92%
20.04.26
20.04.26
